Disparate effect of tamoxifen in rats with experimentally induced endometriosis

Kadaba R, R. KADABA, C. Wayne Simpson, C W Simpson, Simpson CW
Endocrinology · 1990 · vol. 126(6) , pp. 3263–3267 · doi:10.1210/endo-126-6-3263 · PMID:2351116 · W2001650297
Lab / animal OA: closed CC0 ⤵ 8 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

Tamoxifen treatment induced regression of experimentally induced endometriosis implants in rats, but their recurrence was observed upon withdrawal or co-administration with estradiol, while progesterone blocked recurrence.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The effect of tamoxifen on the growth of endometrial implants was examined in rats with experimentally induced endometriosis. Administration of tamoxifen (1 mg/kg x day) for 60 days completely regressed the endometrial implants. When tamoxifen treatment was withdrawn, recurrence of endometrial implants was observed. Ectopic endometrial implants regressed completely 2 months after ovariectomy in rats with experimentally induced endometriosis. Tamoxifen administration (1 mg/kg x day) for 60 days to ovariectomized rats with regressed implants led to complete recurrence of ectopic endometrial implants. In ovariectomized rats administration of tamoxifen antagonized estradiol-enhanced thymidine incorporation into uterine DNA, but tamoxifen per se stimulated thymidine incorporation. This indicates the agonist/antagonist nature of tamoxifen. Treatment of rats with tamoxifen blocked the normal estrous cycle. However, serum progesterone levels were higher during tamoxifen treatment in rats with intact ovaries than in ovariectomized rats. When ovariectomized rats with regressed implants were administered tamoxifen (1 mg/kg x day) and progesterone (10 mg/kg x day) for 60 days, recurrence of ectopic endometrial implants was not observed. These findings suggest that tamoxifen is effective in regressing endometrial implants in rats with experimentally induced endometriosis, and ovarian progesterone may have a facilitatory effect.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Disease Models, Animal Disease Models, Animal Endometriosis Tamoxifen Animals Animals DNA DNA DNA Endometriosis Endometriosis Endometriosis Endometrium Endometrium Endometrium Estradiol Estradiol Estradiol Estrus Estrus

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (16)

Cited by (8)

SciLite annotations

chemicals 18
tamoxifen tamoxifen tamoxifen tamoxifen tamoxifen tamoxifen estradiol thymidine tamoxifen thymidine tamoxifen tamoxifen progesterone tamoxifen tamoxifen progesterone tamoxifen progesterone
organisms 8
rattus sp. rattus sp. rattus sp. rattus sp. rattus sp. rattus sp. rattus sp. rattus sp.

Source provenance

europepmc
last seen: 2026-10-17T06:09:56.316927+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:11:40.903767+00:00
scilite
last seen: 2026-05-18T04:57:49.680383+00:00
unpaywall
last seen: 2026-10-17T06:24:38.187582+00:00
License: CC0 · commercial use OK